162
Views
10
CrossRef citations to date
0
Altmetric
Original Research

Eosinophil-to-Monocyte Ratio is a Potential Predictor of Prognosis in Acute Ischemic Stroke Patients After Intravenous Thrombolysis

, , , , , , , , , , , & ORCID Icon show all
Pages 853-862 | Published online: 17 May 2021

References

  • Ishikawa M, Zhang JH, Nanda A, Granger DN. Inflammatory responses to ischemia and reperfusion in the cerebral microcirculation. Front Biosci. 2004;9:1339–1347. doi:10.2741/133014977549
  • Tokgoz S, Kayrak M, Akpinar Z, Seyithanoğlu A, Güney F, Yürüten B. Neutrophil lymphocyte ratio as a predictor of stroke. J Stroke Cerebrovasc Dis. 2013;22:1169–1174. doi:10.1016/j.jstrokecerebrovasdis.2013.01.01123498372
  • Xu JH, He XW, Li Q, et al. Higher platelet-to-lymphocyte ratio is associated with worse outcomes after intravenous thrombolysis in acute ischaemic stroke. Front Neurol. 2019;10:1192. doi:10.3389/fneur.2019.0119231798520
  • Wang J, Ma L, Lin T, Li SJ, Chen LL, Wang DZ. The significance of eosinophils in predicting the severity of acute ischemic stroke. Oncotarget. 2017;8:104238–104246. doi:10.18632/oncotarget.2219929262636
  • Yucel C, Keskin MZ, Cakmak O, et al. Predictive value of pre-operative inflammation-based prognostic scores (neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and monocyte-to-eosinophil ratio) in testicular sperm extraction: a pilot study. Andrology. 2017;5:1100–1104. doi:10.1111/andr.1241728992369
  • Deng X, Wang X, Shen L, et al. Association of eosinophil-to-monocyte ratio with 1-month and long-term all-cause mortality in patients with st-elevation myocardial infarction undergoing primary percutaneous coronary intervention. J Thorac Dis. 2018;10:5449–5458. doi:10.21037/jtd.2018.09.2730416794
  • Maegerlein C, Fischer J, Mönch S, et al. Automated calculation of the Alberta stroke program early ct score: feasibility and reliability. Radiology. 2019;291:141–148. doi:10.1148/radiol.201918122830720400
  • Hacke W, Kaste M, Bluhmki E, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med. 2008;359:1317–1329. doi:10.1056/NEJMoa080465618815396
  • Åsberg S, Farahmand B, Hasvold P, Johansson S, Appelros P. Non-cardioembolic tia and ischemic stroke: implications of severity. Acta Neurol Scand. 2018;138:369–376. doi:10.1111/ane.1297429920644
  • Pan H, Fu M, Ge W, Zhou C. The effects of changes in platelet-to-neutrophil ratios 24 hours after intravenous thrombolysis on prognosis in acute ischemic stroke patients. Clin Neurol Neurosurg. 2020;190:105739. doi:10.1016/j.clineuro.2020.10573932105907
  • DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44:837–845. doi:10.2307/25315953203132
  • Montgomery ND, Dunphy CH, Mooberry M, et al. Diagnostic complexities of eosinophilia. Arch Pathol Lab Med. 2013;137:259–269. doi:10.5858/arpa.2011-0597-RA23368869
  • Weller PF, Spencer LA. Functions of tissue-resident eosinophils. Nat Rev Immunol. 2017;17:746–760. doi:10.1038/nri.2017.9528891557
  • Liberale L, Montecucco F, Bonaventura A, et al. Monocyte count at onset predicts poststroke outcomes during a 90-day follow-up. Eur J Clin Invest. 2017;47:702–710. doi:10.1111/eci.1279528783210
  • Dong X, Nao J, Gao Y. Peripheral monocyte count predicts outcomes in patients with acute ischemic stroke treated with rtpa thrombolysis. Neurotox Res. 2020;37:469–477. doi:10.1007/s12640-019-00103-031478125
  • Foey AD, Parry SL, Williams LM, Feldmann M, Foxwell BM, Brennan FM. Regulation of monocyte il-10 synthesis by endogenous il-1 and tnf-alpha: role of the p38 and p42/44 mitogen-activated protein kinases. J Immunol. 1998;160:920–928.9551930
  • Konstantopoulos K, Grotta JC, Sills C, Wu KK, Hellums JD. Shear-induced platelet aggregation in normal subjects and stroke patients. Thromb Haemost. 1995;74:1329–1334. doi:10.1055/s-0038-16499358607118
  • Ray MJ, Walters DL, Bett JN, Cameron J, Wood P, Aroney CN. Platelet-monocyte aggregates predict troponin rise after percutaneous coronary intervention and are inhibited by abciximab. Int J Cardiol. 2005;101:249–255. doi:10.1016/j.ijcard.2004.03.03315882672
  • Cayrol C, Girard JP. Interleukin-33 (il-33): a nuclear cytokine from the il-1 family. Immunol Rev. 2018;281:154–168. doi:10.1111/imr.1261929247993
  • Bass DA, Gonwa TA, Szejda P, Cousart MS, DeChatelet LR, McCall CE. Eosinopenia of acute infection: production of eosinopenia by chemotactic factors of acute inflammation. J Clin Invest. 1980;65:1265–1271. doi:10.1172/JCI1097897410543
  • Pazdrak K, Straub C, Maroto R, et al. Cytokine-induced glucocorticoid resistance from eosinophil activation: protein phosphatase 5 modulation of glucocorticoid receptor phosphorylation and signaling. J Immunol. 2016;197:3782–3791. doi:10.4049/jimmunol.160102927742828
  • Cowan MJ, Reichenbach D, Turner P, Thostenson C. Cellular response of the evolving myocardial infarction after therapeutic coronary artery reperfusion. Hum Pathol. 1991;22:154–163. doi:10.1016/0046-8177(91)90037-P2001877